List today: InfuSystems Holdings INFU: This rapidly growing healthcare services company that provides state-of-the-art ...

Tempus AI posts a narrower Q2 loss and an 89.6% revenue surge, driven by genomics growth and new oncology-focused product launches.

During a livestream yesterday, OpenAI announced GPT-5, alongside a series of interface and usability improvements to its chatbot.

Eli Lilly stock beats Q2 estimates with strong sales but faces competitive risks and high valuation. Here's why investors may ...

Leede Financial analyst Douglas Loe maintained a “Speculative Buy” rating and $11.00 target on Cardiol Therapeutics ...

REDWOOD CITY, Calif. (AP) — REDWOOD CITY, Calif. (AP) — Coherus Oncology, Inc. (CHRS) on Thursday reported net income of $297.8 million in its second quarter. The Redwood City, California-based ...

Oncolytics Biotech® Inc. (Nasdaq: ONCY) (TSX: ONC) ("Oncolytics" or the "Company"), a clinical-stage immunotherapy company ...

Key opinion leader event and pancreatic cancer clinical data validate decision to engage with regulators on plans for a registration-enabling study New members of the ...

Amgen AMGN delivered yet another strong quarterly performance. Its second-quarter 2025 earnings and sales beat estimates. The ...

Explore our top picks for the best psoriasis lotions, featuring dermatologist-recommended brands like Vanicream and Eucerin.

Lionel Messi's goal against PSV Eindhoven helped the Barcelona star surpass Cristiano Ronaldo for a Champions League record, ...